Saturday, March 21, 2026

Tech Turmoil: Dow, S&P, and Nasdaq Slip Ahead of Microsoft and Meta Reports

U.S. stock markets fell across the board ahead of Big Tech earnings reports released after the closing bell.

Trump Seeks Redemption at U.S.-South Korea Summit After Setback With Putin

Analysts suggest Trump seeks success at the U.S.-South Korea summit after a disappointing U.S.-Russia meeting, focusing on North Korea.

How North Korean Agents Use AI to Secure Remote Jobs in Europe: A Deep Dive

North Korean operatives exploit AI to secure remote jobs in Europe, using fake identities and advanced techniques to bypass security.

Tag: Remsima

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Top News

- Our Sponsors Ad -

Follow us